Additional Safety Risk to Exceptionally Approved Drugs in the EU?

作者:Arnardottir A H; Haaijer Ruskamp F M; Straus S M J M; de Graeff P A; Mol P G
来源:10th International-Society-of-Pharmacovigilance Annual Meeting on Pharmacovigilance in the Global Village, 2010-11-03 to 2010-11-06.
  • 出版日期2010